Tags : Research

Biotech

Egle Identifies First Novel Regulatory T-cell Targets Under its Collaboration

Shots: Egle has achieved the first milestone in its research agreement with Takeda, signed in June’2020. Egle will validate novel tumor-infiltrating regulatory T-cell targets while Takeda will develop the potential therapies Egle has leveraged its unique bioinformatic & translational capabilities to identify targets Following the achievement of the target identification, Egle will receive an R&D […]Read More

Biotech

Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on

Shots: Precision to receive $100M upfront, $35M as an equity investment and will receive $420M as milestones/ product along with royalties on sales of licensed products emerges from the collaboration, making a total deal value ~$2.7B Precision will lead to pre-clinical research and IND-enabling activities while Lilly will lead clinical development and commercialization and have […]Read More

Biotech

Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on

Shots: Precision to receive $100M upfront, $35M as an equity investment and will receive $420M as milestones/ product along with royalties on sales of licensed products emerges from the collaboration, making a total deal value ~$2.7B Precision will lead to pre-clinical research and IND-enabling activities while Lilly will lead clinical development and commercialization and have […]Read More

MedTech

Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test

Shots: TScan signs exclusive research and option to license agreement with Qiagen to develop T cell-based laboratory tests for detecting prior exposure to the SARS-CoV-2 Qiagen gets an option to license the rights and IP for several of TScan discovered immunodominant T cell targets, associated sequences and relevant data for the development and commercialization of […]Read More

Pharma

Sanofi and MD Anderson Sign a Five-Year Pact to Expedite

Shots: Sanofi and MD Anderson collaborated for 5yrs. to ramp up the development of investigational treatments, including targeted and immune-therapies for oncology patients. The alliance will support investigations into additional indications and combinations for studies already in the clinic The collaboration will integrate MD Anderson’s clinical trials infrastructure and Sanofi’s pipeline of investigational treatments to […]Read More

Pharma

BARDA to Fund $1B to AstraZeneca for Research and Development

Shots: The $1B support is for the development, production and delivery of the vaccine with its initiation in H2’20 including a P-III trial with 30,000 participants and a pediatric trial.AZ has initiated to provide wider access to University of Oxford’s vaccine and concluded to provide 400M doses has secured total manufacturing capacity for 1B doses […]Read More